Acquired uniparental disomy of 17p is associated with mutations of TP53 gene in patients with MDS and complex karyotypes.

被引：0

作者：

Svobodova, Karla ^{[1
,2
]}

Zemanova, Zuzana ^{[1
,2
]}

Lhotska, Halka ^{[1
,2
]}

Belickova, Monika ^{[3
]}

Brezinova, Jana ^{[4
]}

Sarova, Iveta ^{[4
]}

Izakova, Silvia ^{[1
,2
]}

Lizcova, Libuse ^{[1
,2
]}

Ransdorfova, Sarka ^{[4
]}

Berkova, Adela ^{[1
,2
]}

Siskova, Magda ^{[1
,5
]}

Jonasova, Anna ^{[1
,5
]}

Cermak, Jaroslav ^{[6
]}

Michalova, Kyra ^{[2
]}

机构：

[1] Gen Univ Hosp, Prague 2, Czech Republic

[2] Charles Univ Prague, Ctr Oncocytogenet, Inst Med Biochem & Lab Diagnost, Fac Med 1, Prague, Czech Republic

[3] Inst Hematol & Blood Transfus, Dept Mol Genet, Prague, Czech Republic

[4] Inst Hematol & Blood Transfus, Dept Cytogenet, Prague, Czech Republic

[5] Charles Univ Prague, Fac Med 1, Med Dept 1, Prague, Czech Republic

[6] Inst Hematol & Blood Transfus, Clinal Dept, Prague, Czech Republic

来源：

CHROMOSOME RESEARCH | 2015年 / 23卷

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

2.P21

引用

页码：S85 / S86

页数：2

共 50 条

[31] INITIALLY AND NEWLY ACQUIRED TP53 MUTATIONS IN PATIENTS WITH MDS WITH DEL(5Q) WITH/WITHOUT LENALIDOMIDE
Ganster, C.
Eder, L.
Rittscher, K.
Brzuszkiewicz, E.
Braulke, F.
Glass, B.
Elmaagacli, A.
Mazzeo, P.
Shirneshan, K.
Haase, D.
LEUKEMIA RESEARCH, 2023, 128
[32] How best to manage patients with chronic lymphocytic leuekmia with 17p deletion and/or TP53 mutation?
Tam, Constantine S.
Stilgenbauer, Stephan
LEUKEMIA & LYMPHOMA, 2015, 56 (03) : 587 - 593
[33] Demonstration of p53 protein and TP53 gene mutations in oligodendrogliomas
Hagel, C
Laking, G
Laas, R
Scheil, S
Jung, R
MildeLangosch, K
Stavrou, DK
EUROPEAN JOURNAL OF CANCER, 1996, 32A (13) : 2242 - 2248
[34] Prognostic Value of TP53 Gene Mutations in Higher Risk MDS Treated with Azacitidine
Bally, Cecile
Ades, Lionel
Renneville, Aline
Preudhomme, Claude
Mozziconacci, Marie-Joelle
de The, Hugues
Lehmann-Che, Jacqueline
Fenaux, Pierre
BLOOD, 2012, 120 (21)
[35] TP53 mutation and 17p deletion are associated with poor survival in patients with CLL irrespective of the inactivation of the other allele by deletion or TP53 mutation:: Results from a single center analysis
Zenz, T.
Haebe, S.
Kroeber, A.
Benner, A.
Kienle, D.
Buehler, A.
Denzel, T.
Winkler, D.
Doehner, H.
Stilgenbauer, S.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 35 - 35
[36] 17p Deletion in CLL: Detailed Analysis of TP53 Mutations, Alternative Mechanisms of p53 Inactivation, Clone Size and Clonal Evolution
Zenz, Thorsten
Sarno, Antonio
Haebe, Sonja
Denzel, Tina
Mohr, Julia
Vollmer, Dominik
Heuberger, Maria
Winkler, Dirk
Kienle, Dirk
Buehler, Andreas
Truong, Sim
Patten, Nancy
Hallek, Michael
Doehner, Hartmut
Stilgenbauer, Stephan
BLOOD, 2008, 112 (11) : 291 - 291
[37] TP53 gene mutations in plasma DNA of cancer patients
Silva, JM
Gonzalez, R
Dominguez, G
Garcia, JM
España, P
Bonilla, F
GENES CHROMOSOMES & CANCER, 1999, 24 (02): : 160 - 161
[38] Clinical characteristics and overall survival among acute myeloid leukemia patients with TP53 gene mutation or chromosome 17p deletion
Daver, Naval G.
Iqbal, Shahed
Huang, Julie
Renard, Camille
Lin, Joyce
Pan, Yang
Williamson, Mellissa
Ramsingh, Giridharan
AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (08) : 1176 - 1184
[39] Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype
Haferlach, C.
Dicker, F.
Herholz, H.
Schnittger, S.
Kern, W.
Haferlach, T.
LEUKEMIA, 2008, 22 (08) : 1539 - 1541
[40] Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype
C Haferlach
F Dicker
H Herholz
S Schnittger
W Kern
T Haferlach
Leukemia, 2008, 22 : 1539 - 1541

← 1 2 3 4 5 →